51 filings
8-K
LABP
Landos Biopharma Inc
25 Mar 24
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
8:54am
8-K
LABP
Landos Biopharma Inc
21 Mar 24
Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results
8:08am
8-K
LABP
Landos Biopharma Inc
4 Jan 24
Regulation FD Disclosure
8:05am
8-K
LABP
Landos Biopharma Inc
21 Nov 23
Landos Biopharma Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis in Journal of Crohn’s and Colitis
8:08am
8-K
LABP
Landos Biopharma Inc
9 Nov 23
Landos Biopharma Provides Company Update and Reports Third Quarter 2023 Results
8:08am
8-K
6a65xepziwow0kwv xo
21 Sep 23
Departure of Directors or Certain Officers
8:00am
8-K
cn6 zehe3je
14 Sep 23
Collaboration Will Focus on Defining the Effects Of NX-13 in Ulcerative Colitis Patient Derived Organoid Models
8:11am
8-K
gkg9p vp5
9 Aug 23
Landos Biopharma Provides Business Update & Reports Second Quarter 2023 Results
8:12am
8-K
qt7p 9vj3xs
30 May 23
Departure of Directors or Certain Officers
4:53pm
8-K
hqtpn2f
25 May 23
Landos Biopharma Announces 1-for-10 Reverse Stock Split
4:19pm
8-K
34y949 qv
12 May 23
Landos Biopharma Provides Business Update and Reports First Quarter 2023 Results
8:40am
8-K
9txpaysgxpte
23 Mar 23
Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2022 Results
8:15am
8-K
yvj4x713h1 l29j1oaa
10 Mar 23
Other Events
5:23pm
8-K
0qkl0gnjd6qwf0 6j
28 Feb 23
Asset Purchase and Redemption Agreement
5:20pm
8-K
bojyxxudnbcjirup53
13 Jan 23
Entry into a Material Definitive Agreement
8:35am
8-K
mt07us 1q9
5 Jan 23
Landos Biopharma Provides Comprehensive Update on Clinical Development Plans
7:30am
8-K
lnib4yeaqhaggp
5 Jan 23
Landos Biopharma Announces $16.7 Million Private Placement Financing
7:30am
8-K
y87b5uzq3sg6
16 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:31am
8-K
xmlr899ej83m
10 Nov 22
Landos Biopharma Reports Third Quarter 2022 Results and Provides Business Update
8:15am
8-K
vie15j
11 Aug 22
Landos Biopharma Reports Second Quarter 2022 Results and Provides Business Update
8:54am